Christopher Thatcher

Christopher A. Thatcher is the President and Chief Executive Officer at Neuronetics, Inc. He has over 20 years of experience specializing in the development and successful commercialization of new medical device products. Currently at Neuronetics, Mr. Thatcher is the driving force for this pioneer and innovator in Transcranial Magnetic Stimulation therapy for Major Depressive Disorder. His focus is on continuing to accelerate its position as a global market leader in TMS with the NeuroStar TMS Therapy System. Mr. Thatcher has previously held executive positions at Reichert Technologies, a unit of AMETEK Ultra Precision Technologies, Integra Lifesciences, Bausch and Lomb, and Allergan. His strengths in optimizing product development, strategic decision-making, and streamlining operations will be of great value to MID.